This is an archive of the Selling Sickness 2013 conference, held in Washington DC in February 2013. It is preserved as a record and is no longer updated.

Selling Sickness 2013 — People Before Profits

INCHING TOWARDS “THE PATIENT REVOLUTION”

Escalating calls for a “patient revolution” are pouring in from the blogs and books of doctors, researchers, patients, activists, and all sorts of policy people. The movement is not all new, however. In “Towards the Emancipation of Patients: Patients' Experiences and the Patient Movement” (2010), UK patient advocate Charlotte Williamson reviews the international rise of the patient movement in the 1960s and 70s, fuelled, she argues, by changing attitudes towards authorities (doctors are no longer gods) and growing public awareness about all the kinds of problems in the health care system that result in poor quality health care.

Now of course, with the internet to put everyone in easy touch with like-minded and like-experienced people, the number of projects and organizations claiming to work on behalf of patients is multiplying exponentially. Some are hand-to-mouth mom-and-pop operations (opens in a new tab) working from the kitchen table and some are huge and well-funded operations (opens in a new tab) that can invite Bill Clinton to their “summits.”

Though they are diverse, the major emphases (opens in a new tab) of these groups seem to reduce to four:

The SELLING SICKNESS movement is committed to raising the visibility (and audibility) of the patient voice - as consumer, as citizen, as advocate. It is at the top of our agenda. But our perspective seems a little different than that of these other patient groups. In much of the patient-centered literature we miss explicit attention to what patients need to know about how thoroughly corporate profits pervade the research and marketing of medical tests and treatments.

Advocating for patients is more than just advocating for access, it’s about advocating for transparency and for quality. Without the part of the analysis about corporate power, activism for patient rights and patient engagement will lack the full arsenal of strategies because it lacks awareness of just what kind of water we are all swimming in. This was brought home to me (L.T.) this week by a wonderful new book (opens in a new tab), “Lethal But Legal: Corporations, Consumption, and Protecting Public Health,” by public health sociologist Nicholas Freudenberg in New York. I will write about it soon.

 

Top